
Panendoscopy’s role in detecting second synchronous primary cancers (SSPCA) in head and neck squamous cell carcinoma (HNSCC) is limited. Despite its low complication rate of 0.7%, it impacts management in just 1.1% of cases after CT scans and 0% after PET scans. Panendoscopy incurs significant costs, ranging from $3802 to $17,296. Overall, its use should focus on confirming suspicious findings, with further research on cost-effectiveness in public systems.
Like
Save
Share